Therapeutics

ABT-288

Tools

Back to the Top

Overview

Name: ABT-288
Therapy Type: Small Molecule
Target Type: Other Neurotransmitters
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Company: AbbVie

Background

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

Papers

  1. . A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia. J Alzheimers Dis. 2014 Jul 2; PubMed.